|
|
Alvotech
ALVO's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Alvotech's sales fell
in IV. Quarter 2023 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
deterioration of revenues by -1.86 %
• More on ALVO's Growth
|
|
Alvotech
reported net loss of 0 millions in the past twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.59.
• More on ALVO's Valuation
|
|
|
|
|
Alvotech
reported net loss of 0 millions in the past twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.59.
| | | |
